Cases & Deals

  • Home
  • Practices
  • Boca Pharmacal acquired by Endo Health for $225 million

Share

Boca Pharmacal acquired by Endo Health for $225 million

February 2014

Client(s) Boca Life Science Holdings, LLC and Boca Pharmacal, LLC

Jones Day advised Boca Life Science Holdings, LLC and Boca Pharmacal, LLC in regards to the sale of all the outstanding limited liability company membership interests of Boca Pharmacal, LLC to Generics International (US) Inc., an Endo Health Solutions' subsidiary, for $225 million in cash.

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.